GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jacobio Pharmaceuticals Group Co Ltd (STU:77V) » Definitions » Piotroski F-Score

Jacobio Pharmaceuticals Group Co (STU:77V) Piotroski F-Score : 0 (As of Mar. 30, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Jacobio Pharmaceuticals Group Co Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 0 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Jacobio Pharmaceuticals Group Co has an F-score of 1. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Jacobio Pharmaceuticals Group Co's Piotroski F-Score or its related term are showing as below:

During the past 7 years, the highest Piotroski F-Score of Jacobio Pharmaceuticals Group Co was 7. The lowest was 0. And the median was 3.


Jacobio Pharmaceuticals Group Co Piotroski F-Score Historical Data

The historical data trend for Jacobio Pharmaceuticals Group Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jacobio Pharmaceuticals Group Co Piotroski F-Score Chart

Jacobio Pharmaceuticals Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial 7.00 3.00 2.00 - -

Jacobio Pharmaceuticals Group Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 - - - -

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was €-46.12 Mil.
Cash Flow from Operations was €-46.77 Mil.
Revenue was €8.16 Mil.
Gross Profit was €0.41 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (213.214 + 187.566) / 2 = €200.39 Mil.
Total Assets at the begining of this year (Dec22) was €213.21 Mil.
Long-Term Debt & Capital Lease Obligation was €15.66 Mil.
Total Current Assets was €150.06 Mil.
Total Current Liabilities was €26.34 Mil.
Net Income was €-50.35 Mil.

Revenue was €12.96 Mil.
Gross Profit was €1.71 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (239.245 + 213.214) / 2 = €226.2295 Mil.
Total Assets at the begining of last year (Dec21) was €239.25 Mil.
Long-Term Debt & Capital Lease Obligation was €18.23 Mil.
Total Current Assets was €181.27 Mil.
Total Current Liabilities was €21.10 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Jacobio Pharmaceuticals Group Co's current Net Income (TTM) was -46.12. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Jacobio Pharmaceuticals Group Co's current Cash Flow from Operations (TTM) was -46.77. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-46.121/213.214
=-0.21631319

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-50.352/239.245
=-0.21046208

Jacobio Pharmaceuticals Group Co's return on assets of this year was -0.21631319. Jacobio Pharmaceuticals Group Co's return on assets of last year was -0.21046208. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Jacobio Pharmaceuticals Group Co's current Net Income (TTM) was -46.12. Jacobio Pharmaceuticals Group Co's current Cash Flow from Operations (TTM) was -46.77. ==> -46.77 <= -46.12 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=15.664/200.39
=0.07816757

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=18.234/226.2295
=0.08059957

Jacobio Pharmaceuticals Group Co's gearing of this year was 0.07816757. Jacobio Pharmaceuticals Group Co's gearing of last year was 0.08059957. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=150.056/26.344
=5.69602186

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=181.272/21.103
=8.58986874

Jacobio Pharmaceuticals Group Co's current ratio of this year was 5.69602186. Jacobio Pharmaceuticals Group Co's current ratio of last year was 8.58986874. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Jacobio Pharmaceuticals Group Co's number of shares in issue this year was 772.842. Jacobio Pharmaceuticals Group Co's number of shares in issue last year was 751.876. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.411/8.158
=0.05038

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1.711/12.964
=0.13198087

Jacobio Pharmaceuticals Group Co's gross margin of this year was 0.05038. Jacobio Pharmaceuticals Group Co's gross margin of last year was 0.13198087. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=8.158/213.214
=0.03826203

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=12.964/239.245
=0.05418713

Jacobio Pharmaceuticals Group Co's asset turnover of this year was 0.03826203. Jacobio Pharmaceuticals Group Co's asset turnover of last year was 0.05418713. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+0+1+0+0+0+0
=1

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Jacobio Pharmaceuticals Group Co has an F-score of 1. It is a bad or low score, which usually implies poor business operation.

Jacobio Pharmaceuticals Group Co  (STU:77V) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Jacobio Pharmaceuticals Group Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Jacobio Pharmaceuticals Group Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Jacobio Pharmaceuticals Group Co Business Description

Traded in Other Exchanges
Address
No. 88, Kechuang 6th Street, Building F2, Beijing Economic-Technological Development Area, Beijing, CHN
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of innovative oncology therapies.

Jacobio Pharmaceuticals Group Co Headlines

No Headlines